In this context, it should be mentioned that in MDA-MB 231 breast cancer cells lacking or minimally expressing GPER (13, 14, 57), the treatment with 2 μM G-1 led to a suppression of cell growth, which persisted also using the GPER antagonist G-15 (79). The gene discussed is GPER1; the disease is breast cancer.